会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
    • 新的4-甲氧基吡咯烷酮衍生物或其盐及其包含其的药物组合物
    • KR101613245B1
    • 2016-04-18
    • KR1020160013588
    • 2016-02-03
    • 주식회사 대웅제약
    • 이춘호이승철이연임엄덕기한미령고은지
    • C07D207/48C07D207/30C07D207/335C07D207/36
    • C07D207/48
    • 본발명은 4-메톡시피롤유도체또는이의약학적으로허용가능한염, 이의제조방법, 및이를포함하는약학조성물을제공한다. 상기 4-메톡시피롤유도체또는이의약학적으로허용가능한염은우수한프로톤펌프억제활성, 위손상억제활성및 방어인자증강효과를가질뿐만아니라, 우수한헬리코박터파일로리() 제균활성을가짐으로써, 위장관궤양, 위염, 역류성식도염, 또는헬리코박터파일로리()에의한위장관손상의예방및 치료에유용하게적용될수 있다. 더욱이, 상기 4-메톡시피롤유도체또는이의약학적으로허용가능한염은 GPCR에대한억제작용을가져, 5-HT 수용체또는무스카린성아세틸콜린수용체매개질환의예방및 치료에유용하다.
    • 本发明提供4-甲氧基吡咯衍生物或其药学上可接受的盐,其制备方法和包含其的药物组合物。 4-甲氧基吡咯衍生物或其药学上可接受的盐具有优异的质子泵抑制活性,对胃损伤的抑制活性,以及​​增加防御因素的作用。 此外,4-甲氧基吡咯衍生物或其药学上可接受的盐对幽门螺杆菌(幽门螺杆菌)具有优异的抑菌活性,因此可用于预防和治疗胃肠溃疡,胃炎,反流性食管炎或由 幽门螺杆菌(幽门螺杆菌)。 此外,4-甲氧基吡咯衍生物或其药学上可接受的盐对GPCR具有抑制活性,因此可用于预防和治疗由5-HT受体或毒蕈碱性乙酰胆碱受体介导的疾病。
    • 6. 发明公开
    • 글리메피라이드의 제조방법
    • 环境友好的制造方法,使用无苯乙酸甲酯和反式-4-甲基环己基甲硅烷酸酯制备GLIMEPIRIDE,其使用高纯度和有效性的死亡POASON气体是昂贵的和准备的
    • KR1020050017776A
    • 2005-02-23
    • KR1020030055110
    • 2003-08-08
    • 명문제약주식회사
    • 윤여홍성창용
    • C07D207/36
    • PURPOSE: A process for manufacturing glimepiride is provided, which glimepiride is environment-friendly manufactured by using no phenylethylisocyanate and trans-4-methyl-cyclohexylisocyanate which are expensive and prepared by using deadly poison gas with high purity and yield. CONSTITUTION: The process for manufacturing glimepiride of reaction formula (2) comprises the steps of: (a) reacting hydroxycarbamoyl chloride(HCC) with sodiumazide to prepare hydroxycarbamoylazide, and reacting it with 3-ethyl-4-methyl-2-oxo-3-pyroline at 40 to 120 deg. C to prepare 3-ethyl-4-methyl-2-oxo-3-pyroline-1-(N-2-phenylethyl)-carboxamide of formula (3); (b) reacting 3-ethyl-4-methyl-2-oxo-3-pyroline-1-(N-2-phenylethyl)-carboxamide with chlorosulfonate to prepare 4-£2-(3-ethyl-4-methyl-2-oxo-3-pyroline-1-carboxamido)-ethyl|-benzenesulfonylchloride, and reacting it with ammonia to prepare 4-£2-(3-ethyl-4-methyl-2-oxo-3-pyroline-1-carboxamido)-ethyl|-benzenesulfonamide of formula (4); and (c) reacting 4-£2-(3-ethyl-4-methyl-2-oxo-3-pyroline-1-carboxamido)-ethyl|-benzenesulfonamide of formula (4) with an activated intermediate prepared by reacting N,N-carbonyldiimidazol(CDI) with trans-4-methyl-cyclohexylamine of formula (6), in the presence of base, wherein the base is organic base, alkali earth metal inorganic base or alkali metal inorganic base.
    • 目的:提供了一种制备格列美脲的方法,通过使用不含苯乙基异氰酸酯和反式-4-甲基 - 环己基异氰酸酯,格列美脲是昂贵的,通过使用高纯度和高产率的致命毒性制备而成的环境友好型。 构成:制备反应式(2)的格列美脲的方法包括以下步骤:(a)使羟基氨基甲酰氯(HCC)与叠氮化钠反应以制备羟基氨基甲酰基叠氮化物,并与3-乙基-4-甲基-2-氧代-3 - 脯氨酸在40〜120℃。 制备式(3)的3-乙基-4-甲基-2-氧代-3-热解-1-(N-2-苯乙基) - 甲酰胺; (b)使3-乙基-4-甲基-2-氧代-3-热解-1-(N-2-苯基乙基) - 甲酰胺与氯磺酸盐反应制备4-(2-乙基-4-甲基-2- (3-乙基-4-甲氧基-3-吡咯烷-1-甲酰胺基) - 乙基} - 苯磺酰氯,并与氨反应制备4- {2-(3-乙基-4-甲基-2-氧-3-吡咯烷-1-甲酰氨基) (4)的 - 乙基| - 苯磺酰胺; 和(c)使式(4)的4-(2-乙基-4-甲基-2-氧代-3-焦环线-1-甲酰胺基) - 乙基| - 苯磺酰胺与活化的中间体反应, 在碱的存在下,将式(6)的反式-4-甲基 - 环己胺与N-烷基二咪唑(CDI)反应,其中碱为有机碱,碱土金属无机碱或碱金属无机碱。
    • 7. 发明授权
    • 치환된1H-3-아릴-피롤리딘-2,4-디온유도체
    • 치환된1H -3-아릴 - 피롤리딘-2,4-디온유도체
    • KR100377349B1
    • 2003-08-25
    • KR1019950002074
    • 1995-02-06
    • 바이엘 악티엔게젤샤프트
    • 라이너피셔토마스브레트쉬나이더베른트-빌란트크뤼거미카엘루터크리스토프에르델렌울리케바헨도르프-노이만한스-요하힘잔텔마르쿠스돌링거
    • C07D207/36A01N43/36
    • C07D491/10A01N43/36A01N43/38A01N43/90A01N47/06A01N47/18C07D207/38C07D209/96C07F9/5725
    • 1H-3-aryl-pyrrolidine-2,4-dione derivs. of formula (I), their diastereomer mixts. pure diastereomers and enantiomers are new. A = alkyl, alkenyl, alkoxy, alkyl, alkylthioalkyl (all opt. substd. with halogen) cycloalkyl (opt. interrupted with at least one heteroatom and opt. substd.), aryl, arylalkyl or heteroaryl (these last 3 gps. each opt substd. with halogen, alkyl, haloalkyl, alkoxy or NO2) or H; B = H, alkyl or alkoxyalkyl; or CAB = opt satd. ring (opt. interrupted with at least one heteroatom and opt. substd.); X = halogen or alkyl; when X = halogen then Y alkyl; when X = alkyl then Y = halogen; G = H, a metal ion equivalent, an ammonium ion, COR1, C(=L)-MR2, SO2R3, P(=L)R4R5 or C(=L)-NR6R7; L, M = O or S; R1 = alkyl, alkenyl, alkoxy, alkyl, alkylthioalkyl, polyoxyalkyl (all opt. substd. with halogen), cycloalkyl (opt. substd. with halogen or alkyl and opt. interrupted with at least one heteroatom) Ph, phenylalkyl, heteroaryl, phenoxyalkyl or heteroaryloxyalkyl (these last 5 each opt. substd); R2 = alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl (all opt. substd. with halogen), cycloalkyl, Ph or benzyl (these 3 each opt. substd); R3-R5 = alkyl, alkoxy, alkylamino, dialkylamino, alkylthio, alkenylthio, cycloalkylthio (all opt. substd. with halogen), Ph, OPh or SPh (these 3 each opt. substd); R6 and R7 = alkyl, cycloalkyl, alkenyl, alkoxy, alkoxyalkyl (all opt. substd. with halogen), Ph or benzyl (both opt. substd) or H; or NR6R7 = heterocycle opt. interrupted with O or S.
    • 1H-3-芳基 - 吡咯烷-2,4-二酮衍生物。 (I)的化合物,它们的非对映体混合物。 纯非对映体和对映体是新的。 A =烷基,烯基,烷氧基,烷基,烷硫基烷基(全部可以被卤素取代),环烷基(可被至少一个杂原子插入并且可以被取代),芳基,芳基烷基或杂芳基(这些最后3个gps, 用卤素,烷基,卤代烷基,烷氧基或NO 2取代)或H; B = H,烷基或烷氧基烷基; 或CAB = opt satd。 环(可选中断,至少有一个杂原子,并且可选)。 X =卤素或烷基; 当X =卤素时,则Y烷基; 当X =烷基时,则Y =卤素; G = H,金属离子等价物,铵离子,COR1,C(= L)-MR2,SO2R3,P(= L)R4R5或C(= L)-NR6R7; L,M = O或S; R 1 =烷基,链烯基,烷氧基,烷基,烷硫基烷基,聚氧烷基(全部可以被卤素取代),环烷基(可被卤素或烷基取代并且被至少一个杂原子插入),苯基烷基,杂芳基, 或杂芳氧基烷基(这些最后5个各自选择取代); R 2 =烷基,链烯基,烷氧基烷基,聚烷氧基烷基(全部可以被卤素取代),环烷基,Ph或苄基(这些每个都可以被取代)。 R 3 -R 5 =烷基,烷氧基,烷基氨基,二烷基氨基,烷硫基,烯硫基,环烷硫基(全部可以被卤素取代),Ph,OPh或SPh(这些3各自任选取代)。 R6和R7 =烷基,环烷基,链烯基,烷氧基,烷氧基烷基(都可以用卤素取代),Ph或苄基(均可以取代)或H; 或NR6R7 =杂环选择。 用O或S打断。